<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2017-10-25" version="170">
<accession>P49427</accession>
<accession>A8K689</accession>
<name>UB2R1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ubiquitin-conjugating enzyme E2 R1</fullName>
<ecNumber evidence="15 20 25 26">2.3.2.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>(E3-independent) E2 ubiquitin-conjugating enzyme R1</fullName>
<ecNumber evidence="19">2.3.2.24</ecNumber>
</alternativeName>
<alternativeName>
<fullName>E2 ubiquitin-conjugating enzyme R1</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-conjugating enzyme E2-32 kDa complementing</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-conjugating enzyme E2-CDC34</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-protein ligase R1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDC34</name>
<name type="synonym">UBCH3</name>
<name type="synonym">UBE2R1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="10484" last="10488">
<title>Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast.</title>
<authorList>
<person name="Plon S.E."/>
<person name="Leppig K.A."/>
<person name="Do H.N."/>
<person name="Groudine M."/>
</authorList>
<dbReference type="PubMed" id="8248134"/>
<dbReference type="DOI" id="10.1073/pnas.90.22.10484"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT HIS-227</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="14823" last="14830">
<title>Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha.</title>
<authorList>
<person name="Gonen H."/>
<person name="Bercovich B."/>
<person name="Orian A."/>
<person name="Carrano A."/>
<person name="Takizawa C."/>
<person name="Yamanaka K."/>
<person name="Pagano M."/>
<person name="Iwai K."/>
<person name="Ciechanover A."/>
</authorList>
<dbReference type="PubMed" id="10329681"/>
<dbReference type="DOI" id="10.1074/jbc.274.21.14823"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-93</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5001" last="5013">
<title>Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis.</title>
<authorList>
<person name="Pati D."/>
<person name="Meistrich M.L."/>
<person name="Plon S.E."/>
</authorList>
<dbReference type="PubMed" id="10373550"/>
<dbReference type="DOI" id="10.1128/MCB.19.7.5001"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Cell Sci." volume="113" first="1687" last="1694">
<title>Association of human ubiquitin-conjugating enzyme CDC34 with the mitotic spindle in anaphase.</title>
<authorList>
<person name="Reymond F."/>
<person name="Wirbelauer C."/>
<person name="Krek W."/>
</authorList>
<dbReference type="PubMed" id="10769200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="2986" last="2995">
<title>Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.</title>
<authorList>
<person name="Charrasse S."/>
<person name="Carena I."/>
<person name="Brondani V."/>
<person name="Klempnauer K.H."/>
<person name="Ferrari S."/>
</authorList>
<dbReference type="PubMed" id="10871850"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203618"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="3529" last="3536">
<title>SCF(beta-TRCP) and phosphorylation dependent ubiquitination of I kappa B alpha catalyzed by Ubc3 and Ubc4.</title>
<authorList>
<person name="Strack P."/>
<person name="Caligiuri M."/>
<person name="Pelletier M."/>
<person name="Boisclair M."/>
<person name="Theodoras A."/>
<person name="Beer-Romero P."/>
<person name="Glass S."/>
<person name="Parsons T."/>
<person name="Copeland R.A."/>
<person name="Auger K.R."/>
<person name="Benfield P."/>
<person name="Brizuela L."/>
<person name="Rolfe M."/>
</authorList>
<dbReference type="PubMed" id="10918611"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203647"/>
</citation>
<scope>INTERACTION WITH SCF COMPLEX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="41049" last="41058">
<title>Phosphorylation of the human ubiquitin-conjugating enzyme, CDC34, by casein kinase 2.</title>
<authorList>
<person name="Block K."/>
<person name="Boyer T.G."/>
<person name="Yew P.R."/>
</authorList>
<dbReference type="PubMed" id="11546811"/>
<dbReference type="DOI" id="10.1074/jbc.M106453200"/>
</citation>
<scope>INTERACTION WITH CSNK2B</scope>
<scope>PHOSPHORYLATION AT SER-203; SER-222; SER-231; THR-233 AND SER-236</scope>
<scope>MUTAGENESIS OF SER-203; SER-222; SER-231; THR-233 AND SER-236</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="8815" last="8820">
<title>The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.</title>
<authorList>
<person name="Van Sant C."/>
<person name="Hagglund R."/>
<person name="Lopez P."/>
<person name="Roizman B."/>
</authorList>
<dbReference type="PubMed" id="11447293"/>
<dbReference type="DOI" id="10.1073/pnas.161283098"/>
</citation>
<scope>INTERACTION WITH HUMAN HERPESVIRUS 1 PROTEIN ICP0</scope>
<scope>ASSOCIATION WITH THE PROTEASOME</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="516" last="527">
<title>The Nedd8-conjugated ROC1-CUL1 core ubiquitin ligase utilizes Nedd8 charged surface residues for efficient polyubiquitin chain assembly catalyzed by Cdc34.</title>
<authorList>
<person name="Wu K."/>
<person name="Chen A."/>
<person name="Tan P."/>
<person name="Pan Z.Q."/>
</authorList>
<dbReference type="PubMed" id="11675391"/>
<dbReference type="DOI" id="10.1074/jbc.M108008200"/>
</citation>
<scope>INTERACTION WITH SCF COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="3978" last="3987">
<title>CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation.</title>
<authorList>
<person name="Semplici F."/>
<person name="Meggio F."/>
<person name="Pinna L.A."/>
<person name="Oliviero S."/>
</authorList>
<dbReference type="PubMed" id="12037680"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205574"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BTRC</scope>
<scope>PHOSPHORYLATION AT SER-231</scope>
<scope>MUTAGENESIS OF CYS-93; LEU-97 AND SER-231</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="631" last="636">
<title>Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.</title>
<authorList>
<person name="Hagglund R."/>
<person name="Van Sant C."/>
<person name="Lopez P."/>
<person name="Roizman B."/>
</authorList>
<dbReference type="PubMed" id="11805320"/>
<dbReference type="DOI" id="10.1073/pnas.022531599"/>
</citation>
<scope>INTERACTION WITH HUMAN HERPES VIRUS 1 PROTEIN ICP0</scope>
<scope>AUTOUBIQUITINATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="7889" last="7894">
<title>Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0.</title>
<authorList>
<person name="Hagglund R."/>
<person name="Roizman B."/>
</authorList>
<dbReference type="PubMed" id="12060736"/>
<dbReference type="DOI" id="10.1073/pnas.122246999"/>
</citation>
<scope>INTERACTION WITH HUMAN HERPES VIRUS 1 PROTEIN ICP0</scope>
<scope>AUTOUBIQUITINATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Exp. Cell Res." volume="303" first="482" last="493">
<title>The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels.</title>
<authorList>
<person name="Butz N."/>
<person name="Ruetz S."/>
<person name="Natt F."/>
<person name="Hall J."/>
<person name="Weiler J."/>
<person name="Mestan J."/>
<person name="Ducarre M."/>
<person name="Grossenbacher R."/>
<person name="Hauser P."/>
<person name="Kempf D."/>
<person name="Hofmann F."/>
</authorList>
<dbReference type="PubMed" id="15652359"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.10.008"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Biochem. J." volume="405" first="569" last="581">
<title>Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.</title>
<authorList>
<person name="Sadowski M."/>
<person name="Mawson A."/>
<person name="Baker R."/>
<person name="Sarcevic B."/>
</authorList>
<dbReference type="PubMed" id="17461777"/>
<dbReference type="DOI" id="10.1042/BJ20061812"/>
</citation>
<scope>PHOSPHORYLATION AT SER-203; SER-222 AND SER-231</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Mol. Cell" volume="26" first="891" last="898">
<title>E3-independent monoubiquitination of ubiquitin-binding proteins.</title>
<authorList>
<person name="Hoeller D."/>
<person name="Hecker C.M."/>
<person name="Wagner S."/>
<person name="Rogov V."/>
<person name="Doetsch V."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="17588522"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.05.014"/>
</citation>
<scope>CATALYTIC ACTIVITY AS E3-INDEPENDENT E2 UBIQUITIN-CONJUGATING ENZYME</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="7041" last="7052">
<title>Human Cdc34 employs distinct sites to coordinate attachment of ubiquitin to a substrate and assembly of polyubiquitin chains.</title>
<authorList>
<person name="Gazdoiu S."/>
<person name="Yamoah K."/>
<person name="Wu K."/>
<person name="Pan Z.Q."/>
</authorList>
<dbReference type="PubMed" id="17698585"/>
<dbReference type="DOI" id="10.1128/MCB.00812-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ASN-85; TYR-87; SER-95; ASP-102; ASP-103; GLU-108; GLU-112; SER-138; ASP-143; MET-147; ARG-149; LYS-150 AND GLU-153</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="21" last="31">
<title>Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.</title>
<authorList>
<person name="Saha A."/>
<person name="Deshaies R.J."/>
</authorList>
<dbReference type="PubMed" id="18851830"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.08.021"/>
</citation>
<scope>INTERACTION WITH SCF COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Cell" volume="139" first="957" last="968">
<title>Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates.</title>
<authorList>
<person name="Kleiger G."/>
<person name="Saha A."/>
<person name="Lewis S."/>
<person name="Kuhlman B."/>
<person name="Deshaies R.J."/>
</authorList>
<dbReference type="PubMed" id="19945379"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.10.030"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SCF COMPLEX</scope>
<scope>DOMAIN</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5265" last="5276">
<title>Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src.</title>
<authorList>
<person name="Cen B."/>
<person name="Li H."/>
<person name="Weinstein I.B."/>
</authorList>
<dbReference type="PubMed" id="19112177"/>
<dbReference type="DOI" id="10.1074/jbc.M804531200"/>
</citation>
<scope>IDENTIFICATION IN A UBIQUITIN LIGASE COMPLEX WITH HINT1 AND RBX1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="6605" last="6609">
<title>let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts.</title>
<authorList>
<person name="Legesse-Miller A."/>
<person name="Elemento O."/>
<person name="Pfau S.J."/>
<person name="Forman J.J."/>
<person name="Tavazoie S."/>
<person name="Coller H.A."/>
</authorList>
<dbReference type="PubMed" id="19126550"/>
<dbReference type="DOI" id="10.1074/jbc.C900002200"/>
</citation>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="8595" last="8604">
<title>The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines.</title>
<authorList>
<person name="David Y."/>
<person name="Ziv T."/>
<person name="Admon A."/>
<person name="Navon A."/>
</authorList>
<dbReference type="PubMed" id="20061386"/>
<dbReference type="DOI" id="10.1074/jbc.M109.089003"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="784" last="796">
<title>Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate.</title>
<authorList>
<person name="Wu K."/>
<person name="Kovacev J."/>
<person name="Pan Z.Q."/>
</authorList>
<dbReference type="PubMed" id="20347421"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.02.025"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Human ubiquitin-conjugating enzyme cdc34.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 7-184</scope>
</reference>
<reference key="30" evidence="2">
<citation type="journal article" date="2011" name="Cell" volume="145" first="1075" last="1087">
<title>An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.</title>
<authorList>
<person name="Ceccarelli D.F."/>
<person name="Tang X."/>
<person name="Pelletier B."/>
<person name="Orlicky S."/>
<person name="Xie W."/>
<person name="Plantevin V."/>
<person name="Neculai D."/>
<person name="Chou Y.C."/>
<person name="Ogunjimi A."/>
<person name="Al-Hakim A."/>
<person name="Varelas X."/>
<person name="Koszela J."/>
<person name="Wasney G.A."/>
<person name="Vedadi M."/>
<person name="Dhe-Paganon S."/>
<person name="Cox S."/>
<person name="Xu S."/>
<person name="Lopez-Girona A."/>
<person name="Mercurio F."/>
<person name="Wrana J."/>
<person name="Durocher D."/>
<person name="Meloche S."/>
<person name="Webb D.R."/>
<person name="Tyers M."/>
<person name="Sicheri F."/>
</authorList>
<dbReference type="PubMed" id="21683433"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.05.039"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 7-184 IN COMPLEX WITH INHIBITOR 4,5-DIDEOXY-5-(3',5'-DICHLOROBIPHENYL-4-YL)-4-[(METHOXYACETYL)AMINO]-L-ARABINONIC ACID</scope>
</reference>
<reference key="31" evidence="1">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="329" last="341">
<title>A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-function screen.</title>
<authorList>
<person name="Sheng Y."/>
<person name="Hong J.H."/>
<person name="Doherty R."/>
<person name="Srikumar T."/>
<person name="Shloush J."/>
<person name="Avvakumov G.V."/>
<person name="Walker J.R."/>
<person name="Xue S."/>
<person name="Neculai D."/>
<person name="Wan J.W."/>
<person name="Kim S.K."/>
<person name="Arrowsmith C.H."/>
<person name="Raught B."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="22496338"/>
<dbReference type="DOI" id="10.1074/mcp.O111.013706"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 7-184</scope>
<scope>FUNCTION</scope>
<scope>AUTOUBIQUITINATION</scope>
</reference>
<reference key="32" evidence="3">
<citation type="journal article" date="2014" name="Nat. Chem. Biol." volume="10" first="156" last="163">
<title>E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin.</title>
<authorList>
<person name="Huang H."/>
<person name="Ceccarelli D.F."/>
<person name="Orlicky S."/>
<person name="St-Cyr D.J."/>
<person name="Ziemba A."/>
<person name="Garg P."/>
<person name="Plamondon S."/>
<person name="Auer M."/>
<person name="Sidhu S."/>
<person name="Marinier A."/>
<person name="Kleiger G."/>
<person name="Tyers M."/>
<person name="Sicheri F."/>
</authorList>
<dbReference type="PubMed" id="24316736"/>
<dbReference type="DOI" id="10.1038/nchembio.1412"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 7-184 IN COMPLEX WITH INHIBITOR 4,5-DIDEOXY-5-(3',5'-DICHLOROBIPHENYL-4-YL)-4-[(METHOXYACETYL)AMINO]-L-ARABINONIC ACID</scope>
<scope>INTERACTION WITH RBX1</scope>
<scope>MUTAGENESIS OF TYR-70; THR-117; SER-129 AND GLU-133</scope>
</reference>
<comment type="function">
<text evidence="6 7 9 13 15 17 18 20 22 23 24 25 26 27">Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination (PubMed:22496338). Cooperates with the E2 UBCH5C and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Performs ubiquitin chain elongation building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. UBE2D3 acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Cooperates with the SCF(SKP2) E3 ligase complex to regulate cell proliferation through ubiquitination and degradation of MYBL2 and KIP1. Involved in ubiquitin conjugation and degradation of CREM isoform ICERIIgamma and ATF15 resulting in abrogation of ICERIIgamma- and ATF5-mediated repression of cAMP-induced transcription during both meiotic and mitotic cell cycles. Involved in the regulation of the cell cycle G2/M phase through its targeting of the WEE1 kinase for ubiquitination and degradation. Also involved in the degradation of beta-catenin. Is target of human herpes virus 1 protein ICP0, leading to ICP0-dependent dynamic interaction with proteasomes (PubMed:10329681, PubMed:10373550, PubMed:10871850, PubMed:11675391, PubMed:12037680, PubMed:15652359, PubMed:17461777, PubMed:17698585, PubMed:19112177, PubMed:19126550, PubMed:19945379, PubMed:20061386, PubMed:20347421).</text>
</comment>
<comment type="catalytic activity">
<text evidence="4 5 15 20 25 26">S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.</text>
</comment>
<comment type="catalytic activity">
<text evidence="19">S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="13">CDC34-catalyzed polyubiquitin chain assembly activity is stimulated by the conjugation of NEDD8 to the CUL1 SCF E3 ligase complex subunit.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="24">0.11 uM for beta-catenin-monoubiquin</KM>
</kinetics>
</comment>
<comment type="pathway" evidence="4">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="10 11 12 13 14 15 16 21 22 24 28">Interacts with SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex. Identified in a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex together with HINT1 and RBX1. When cullin is neddylated, the interaction between the E2 and the SCF complex is strengthened (PubMed:10918611, PubMed:11675391, PubMed:18851830, PubMed:19945379, PubMed:19112177, PubMed:24316736). When phosphorylated, interacts with beta-TrCP (BTRC) (PubMed:12037680). Interacts with human herpes virus 1 protein ICP0 and associates with the proteasome for degradation (PubMed:11447293, PubMed:11805320, PubMed:12060736). Interacts with casein kinase subunit CSNK2B (PubMed:11546811).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-975634"/>
<interactant intactId="EBI-359390">
<id>Q13616</id>
<label>CUL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-975634"/>
<interactant intactId="EBI-727004">
<id>O00560</id>
<label>SDCBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-975634"/>
<interactant intactId="EBI-747107">
<id>Q8IUQ4</id>
<label>SIAH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>The phosphorylation of the C-terminal tail plays an important role in mediating nuclear localization. Colocalizes with beta-tubulin on mitotic spindles in anaphase.</text>
</comment>
<comment type="tissue specificity">
<text evidence="7">Expressed in testes during spermatogenesis to regulate repression of cAMP-induced transcription.</text>
</comment>
<comment type="induction">
<text evidence="23">Negatively regulated by the let-7 microRNA.</text>
</comment>
<comment type="domain">
<text evidence="8 24">The C-terminal acidic tail is required for nuclear localization and is involved in the binding to SCF E3 ligase complexes, and more specifically with the CUL1 subunit.</text>
</comment>
<comment type="PTM">
<text evidence="14 16 27">Autoubiquitinated (PubMed:22496338, PubMed:11805320, PubMed:12060736). Autoubiquitination is promoted by the human herpes virus 1 protein ICP0 and leads to degradation by the Ubiquitin-proteasomal pathway (PubMed:11805320, PubMed:12060736).</text>
</comment>
<comment type="PTM">
<text evidence="12 15 18">Phosphorylated by CK2. Phosphorylation of the C-terminal tail by CK2 controles the nuclear localization.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the ubiquitin-conjugating enzyme family.</text>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC37534" version="1"/>
</conflict>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdc34/"/>
</comment>
<dbReference type="EC" id="2.3.2.23" evidence="15 20 25 26"/>
<dbReference type="EC" id="2.3.2.24" evidence="19"/>
<dbReference type="EMBL" id="L22005">
<property type="protein sequence ID" value="AAC37534.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT006659">
<property type="protein sequence ID" value="AAP35305.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY650399">
<property type="protein sequence ID" value="AAT46688.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291554">
<property type="protein sequence ID" value="BAF84243.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471242">
<property type="protein sequence ID" value="EAW61190.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009850">
<property type="protein sequence ID" value="AAH09850.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018143">
<property type="protein sequence ID" value="AAH18143.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC023979">
<property type="protein sequence ID" value="AAH23979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12030.1"/>
<dbReference type="PIR" id="A49630">
<property type="entry name" value="A49630"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004350.1">
<property type="nucleotide sequence ID" value="NM_004359.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.514997"/>
<dbReference type="PDB" id="2OB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=7-184"/>
</dbReference>
<dbReference type="PDB" id="3RZ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=7-184"/>
</dbReference>
<dbReference type="PDB" id="4MDK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A/B/C/D=7-184"/>
</dbReference>
<dbReference type="PDBsum" id="2OB4"/>
<dbReference type="PDBsum" id="3RZ3"/>
<dbReference type="PDBsum" id="4MDK"/>
<dbReference type="ProteinModelPortal" id="P49427"/>
<dbReference type="SMR" id="P49427"/>
<dbReference type="BioGrid" id="107432">
<property type="interactions" value="62"/>
</dbReference>
<dbReference type="CORUM" id="P49427"/>
<dbReference type="DIP" id="DIP-37783N"/>
<dbReference type="IntAct" id="P49427">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="MINT-238910"/>
<dbReference type="STRING" id="9606.ENSP00000215574"/>
<dbReference type="iPTMnet" id="P49427"/>
<dbReference type="PhosphoSitePlus" id="P49427"/>
<dbReference type="BioMuta" id="CDC34"/>
<dbReference type="DMDM" id="2507505"/>
<dbReference type="EPD" id="P49427"/>
<dbReference type="MaxQB" id="P49427"/>
<dbReference type="PaxDb" id="P49427"/>
<dbReference type="PeptideAtlas" id="P49427"/>
<dbReference type="PRIDE" id="P49427"/>
<dbReference type="DNASU" id="997"/>
<dbReference type="Ensembl" id="ENST00000215574">
<property type="protein sequence ID" value="ENSP00000215574"/>
<property type="gene ID" value="ENSG00000099804"/>
</dbReference>
<dbReference type="GeneID" id="997"/>
<dbReference type="KEGG" id="hsa:997"/>
<dbReference type="UCSC" id="uc002lov.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="997"/>
<dbReference type="DisGeNET" id="997"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000099804.8"/>
<dbReference type="GeneCards" id="CDC34"/>
<dbReference type="HGNC" id="HGNC:1734">
<property type="gene designation" value="CDC34"/>
</dbReference>
<dbReference type="HPA" id="CAB005109"/>
<dbReference type="HPA" id="CAB047311"/>
<dbReference type="HPA" id="HPA002382"/>
<dbReference type="MIM" id="116948">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49427"/>
<dbReference type="OpenTargets" id="ENSG00000099804"/>
<dbReference type="PharmGKB" id="PA26265"/>
<dbReference type="eggNOG" id="KOG0425">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5078">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000110436"/>
<dbReference type="HOGENOM" id="HOG000233454"/>
<dbReference type="HOVERGEN" id="HBG063308"/>
<dbReference type="InParanoid" id="P49427"/>
<dbReference type="KO" id="K02207"/>
<dbReference type="OMA" id="CVKTKTP"/>
<dbReference type="OrthoDB" id="EOG091G0O9F"/>
<dbReference type="PhylomeDB" id="P49427"/>
<dbReference type="TreeFam" id="TF101107"/>
<dbReference type="BRENDA" id="2.3.2.B6">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866652">
<property type="pathway name" value="Synthesis of active ubiquitin: roles of E1 and E2 enzymes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SignaLink" id="P49427"/>
<dbReference type="SIGNOR" id="P49427"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="EvolutionaryTrace" id="P49427"/>
<dbReference type="GeneWiki" id="CDC34"/>
<dbReference type="GenomeRNAi" id="997"/>
<dbReference type="PRO" id="PR:P49427"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000099804"/>
<dbReference type="CleanEx" id="HS_CDC34"/>
<dbReference type="ExpressionAtlas" id="P49427">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P49427">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0061631">
<property type="term" value="F:ubiquitin conjugating enzyme activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035458">
<property type="term" value="P:cellular response to interferon-beta"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006270">
<property type="term" value="P:DNA replication initiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043951">
<property type="term" value="P:negative regulation of cAMP-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090261">
<property type="term" value="P:positive regulation of inclusion body assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043525">
<property type="term" value="P:positive regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070936">
<property type="term" value="P:protein K48-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070848">
<property type="term" value="P:response to growth factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00195">
<property type="entry name" value="UBCc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.10.110.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000608">
<property type="entry name" value="UBQ-conjugat_E2"/>
</dbReference>
<dbReference type="InterPro" id="IPR023313">
<property type="entry name" value="UBQ-conjugating_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR016135">
<property type="entry name" value="UBQ-conjugating_enzyme/RWD"/>
</dbReference>
<dbReference type="Pfam" id="PF00179">
<property type="entry name" value="UQ_con"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54495">
<property type="entry name" value="SSF54495"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00183">
<property type="entry name" value="UBIQUITIN_CONJUGAT_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50127">
<property type="entry name" value="UBIQUITIN_CONJUGAT_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Ubiquitin-conjugating enzyme E2 R1" id="PRO_0000082451">
<location>
<begin position="1"/>
<end position="236"/>
</location>
</feature>
<feature type="region of interest" description="SCF-binding">
<location>
<begin position="190"/>
<end position="236"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="200"/>
<end position="236"/>
</location>
</feature>
<feature type="active site" description="Glycyl thioester intermediate">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="12 18">
<location>
<position position="203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="12 18">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="12 15 18">
<location>
<position position="231"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CK2" evidence="12">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="12">
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16990650." id="VAR_021277" evidence="29">
<original>D</original>
<variation>H</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of RBX1-binding." evidence="28">
<original>Y</original>
<variation>R</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits both mono and polyubiquitination of NFKBIA." evidence="20">
<original>N</original>
<variation>Q</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases polyubiquitination of NFKBIA." evidence="20">
<original>Y</original>
<variation>A</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of function." evidence="6 15">
<original>C</original>
<variation>S</variation>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits both mono and polyubiquitination of NFKBIA." evidence="20">
<original>S</original>
<variation>D</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of function." evidence="15">
<original>L</original>
<variation>S</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-103." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-102." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits both mono and polyubiquitination of NFKBIA; when associated with A-112." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits both mono andpolyubiquitination of NFKBIA; when associated with A-108." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of RBX1-binding." evidence="28">
<original>T</original>
<variation>E</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay." evidence="28">
<original>S</original>
<variation>L</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay." evidence="28">
<original>S</original>
<variation>R</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay." evidence="28">
<original>E</original>
<variation>R</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases monoubiquitination of NFKBIA and inhibits polyubiquitination of NFKBIA." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-147; A-149; A-150 and A-153." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-143; A-149; A-150 and A-153." evidence="20">
<original>M</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-147; A-147; A-150 and A-153." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-143; A-147; A-149 and A-153." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits polyubiquitination of NFKBIA; when associated with A-143; A-147; A-149 and A-150." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CK2. Impairs nuclear localization; when associated with A-222; A-231; A-233 and A-236." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CK2. Impairs nuclear localization; when associated with A-203; A-231; A-233 and A-236." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CK2. Impairs nuclear localization; when associated with A-203; A-222; A-233 and A-236." evidence="12 15">
<original>S</original>
<variation>A</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CK2. Impairs nuclear localization; when associated with A-203; A-222; A-231 and A-236." evidence="12">
<original>T</original>
<variation>A</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CK2. Impairs nuclear localization; when associated with A-203; A-222; A-231 and A-233." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="8"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="28"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="46"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="57"/>
<end position="63"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="66"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="74"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="90"/>
<end position="92"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="120"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="142"/>
<end position="153"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="160"/>
<end position="178"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OB4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3RZ3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MDK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00388"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10133"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10329681"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373550"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10769200"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10871850"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10918611"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11447293"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11546811"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11675391"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11805320"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12037680"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12060736"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15652359"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17461777"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17588522"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17698585"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18851830"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19112177"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19126550"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19945379"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20061386"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20347421"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22496338"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316736"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="236" mass="26737" checksum="258960666B589DB3" modified="1997-11-01" version="2">
MARPLVPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPNTYYEGGYFKA
RLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPPVDDPQSGELPSERWNPTQNV
RTILLSVISLLNEPNTFSPANVDASVMYRKWKESKGKDREYTDIIRKQVLGTKVDAERDG
VKVPTTLAEYCVKTKAPAPDEGSDLFYDDYYEDGEVEEEADSCFGDDEDDSGTEES
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>